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Background
Fed-batch culture bioprocesses are essential for the
production of therapeutic proteins [1]. In these cultures,
concentrated feeds are added during cultivation to pre-
vent nutrient depletion and to extend the growth phase,
thus increasing product concentration [2]. One limita-
tion arises from the low solubility of some amino acids
at high concentrations, in particular tyrosine [3]. This
amino acid is commonly solubilized in separate feeds at
basic pH [4] inducing pH spikes and precipitation when
added in the bioreactor. This work describes the evalua-
tion of several chemically modified tyrosines as alterna-
tive to simplify fed-batch bioprocesses by using single
feeding strategies at neutral pH.
Materials and methods
For solubility experiments, increasing concentrations of
modified tyrosines were solubilized in Merck Millipore
proprietary feed at pH 7,0 until reaching the maximum
solubility. Stability was assessed during 6 months in
Merck Millipore proprietary medium and amino acids
(including modified tyrosine) were quantified by ultra
performance liquid chromatography using ACQ·Tag
Ultra reagent (Waters).
For batch cultures, modified tyrosines were solubilized
at a concentration of 4,5 mM in Merck Millipore proprie-
tary medium depleted in unmodified tyrosine. The control
medium contained 1 mM tyrosine di-sodium salt. CHO-S
cells were seeded at 1.105 cells/ml in 50 ml spin tubes and
incubated at 37°C, 5% CO2, 80% humidity and a rotation
speed of 320 rpm. Growth and viability were monitored
during 11 days using Beckman Coulter ViCell®.
For fed-batch cultures, CHO-S cells expressing a
human monoclonal antibody were seeded at 2.105 cells/
ml in medium containing tyrosine di-sodium salt. Feeds
were added every other day starting at day 3. In the
control, tyrosine di-sodium salt was added in a separate
feed at pH 11 whereas modified tyrosines were solubi-
lized in the main feed at pH 7,0. Glucose was main-
tained at 4 g/L using a separate feed. Growth and
viability were monitored during 14 days using Beckman
Coulter ViCell®.
For antibody analysis, IgG concentrations were deter-
mined by a turbidometric method using Roche Cedex bio
HT®. Intact mass analysis, peptide mapping and glycan
analyses were performed on samples from day 14 using
mass spectrometry and 2-aminobenzamide labeling fol-
lowed by ultra performance liquid chromatography.
Results
Solubility and stability experiments
Chemically modified tyrosines demonstrated an
increased solubility in concentrated feed at neutral pH
in comparison with tyrosine or tyrosine di-sodium salt
(Table 1). The highest solubility was achieved for the
modified tyrosine 4 with a value of 75 g/L. The stability
was assessed by quantification of the modified amino
acid through ultra performance liquid chromatography.
Moreover, no precipitation was detected over a 6
months period indicating that the chemical modification
was stable in the tested conditions.
Batch and fed-batch cultures
The performance in batch culture was determined using
tyrosine depleted media and supplementation with the
different derivates. The growth of CHO-S cells with med-
ium supplemented with modified tyrosine 2 reached only
50% of the growth of the control indicating that this
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molecule may not be able to be taken up by the cells or
to promote growth through alternative mechanisms. This
derivate was not evaluated further. Both modified tyro-
sines 3 and 4 induced a growth comparable to the con-
trol culture until day 6 and were then able to extend the
growth during 2 additional days indicating that both deri-
vates can be used successfully in batch cultures.
In fed-batch mode, modified tyrosines 3 and 4 were
solubilized in a single concentrated feed at pH 7,0 and
added to the culture every other day starting at day 3. The
growth of recombinant CHO-S cells obtained with the
derivates was similar to the control (where tyrosine di-
sodium salt was added through a separate feed at pH 11)
reaching a maximum viable cell density of 14.106 at day 7
(Figure 1A). The titer obtained after 14 days was equiva-
lent in the two feeds and the new single feed process with
final titers around 1,5 g/l (Figure 1B) indicating no nega-
tive effect of the chemical modification on productivity.
Impact of modified tyrosines on the monoclonal antibody
quality attributes
Intact mass, peptide mapping and glycosylation analyses
were performed on the monoclonal antibody to study
the impact of modified tyrosines on the final molecule.
No significant difference could be established in either
the intact mass of the antibody or the detailed analysis
of the tryptic peptides by mass spectrometry. Glycosyla-
tion analysis indicated the same overall glycosylation
pattern with 8,2% GlcNac3Man3Fuc, 72,3% G0F, 7,4%
Man5 and 8,5% G1F glycans. Altogether these data indi-
cated that the use of chemically modified tyrosines in
concentrated feeds did not induce any detectable modi-
fication of the monoclonal antibody.
Conclusions
The chemical modification of tyrosine can improve the
solubility of the amino acid by up to 70 fold.
Modified tyrosines are stable in chemically defined
media and feeds and can be used in batch and fed-batch
mode. The use of these modified amino acids in fed-
batch bioprocesses has no detectable impact on the
monoclonal antibody or the recombinant protein pro-
duced. Altogether, this study demonstrates that modified
amino acids can be used successfully in highly concen-
trated neutral feeds to improve and simplify next gen-
eration fed-batch processes.
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Table 1 Maximum solubility and stability of tyrosine derivates in Merck Millipore proprietary feed or medium at pH 7,0.












< 1 g/l 10 g/l 70 g/l 75 g/l
Stability in medium at pH 7,0 - > 6 months > 6 months > 6 months > 6 months
Figure 1 Performance of the modified tyrosines in fed-batch culture. A: Viable cell density and viability during the fed-batch process. B. IgG
production during the fed-batch culture.
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